| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |